Why So Many Generative AI Initiatives Fail to Deliver ROI And What CFOs Can Do About It
Generative AI has quickly become one of the largest areas of corporate investment. Yet for many companies, the results have been disappointing. CFOs are increasingly being asked the same question by boards and CEOs: Why are we spending so much on AI without seeing commensurate returns?
The problem is rarely the technology itself. In most organizations, GenAI tools work reasonably well. The real challenge is that companies are trying to manage GenAI as a technology project when it is actually an organizational transformation.
Three problems in particular are reducing the success rate of GenAI initiatives:
- Companies measure the wrong outcomes.
- They underinvest in the human side of adoption.
- Finance lacks a consistent framework for evaluating value.
Unless those issues are addressed, many GenAI initiatives will continue to produce more excitement than measurable financial return.
Problem #1: Companies Measure the Wrong Outcomes
Most companies evaluate GenAI using the same logic they use for traditional technology investments: Did it reduce cost? Did it eliminate labor? Did it improve short-term efficiency?
Those are reasonable questions, but they often miss where GenAI creates the greatest value.
The most important benefits of GenAI frequently appear in the form of improved employee effectiveness:
- Faster cycle times
- Better quality decisions
- Higher sales conversion
- More productive managers
- Less rework
- Greater capacity to serve customers
These benefits affect revenue, quality, and growth, not just cost. Consider a large global professional services firm with approximately 500 client-facing consultants that deployed GenAI to support proposal writing and research. The new tool reduced proposal preparation time from 10 hours to 7 hours, a 30% improvement. Initially, finance viewed the pilot as a failure. No positions had been eliminated. Compensation expense remained unchanged. There was no obvious reduction in operating cost.
However, a closer analysis revealed that the firm had been measuring the wrong outcome. Each consultant prepared roughly 20 proposals per year. The three hours saved per proposal generated 30,000 hours of additional consultant capacity annually: 500 consultants × 20 proposals × 3 hours = 30,000 hours
The firm redirected those hours toward client development and revenue-generating work.
Assuming only 20% of those hours translated into billable activity at an average billing rate of $250 per hour, the result was:
30,000 hours × 20% × $250 = $1.5 million in additional annual revenue
The GenAI software, implementation, and training cost $600,000. The net benefit was therefore $900,000, producing a first-year ROI of 150%.
More importantly, proposal win rates increased by 6% because consultants had more time to tailor proposals and respond more quickly to clients.
The lesson is clear: GenAI often creates value by making people more productive, not by making them disappear.
Problem #2: Companies Underinvest in the Human Side of GenAI
Many organizations devote substantial resources to AI software and infrastructure while underinvesting in the workforce changes required to make the technology successful.
GenAI requires more than a new tool. It requires new skills, new workflows, revised job design, management support, and often a rethinking of how work gets done.
Without those complementary investments, even strong technology can fail to produce meaningful returns.
This is not a new phenomenon. Economists have long observed that the value of major technological innovations often lags adoption because organizations must first change the way
people work. The same pattern occurred with electrification, personal computers, and enterprise software.
GenAI is following the same path.
A regional healthcare system with approximately 1,200 nurses implemented GenAI-powered documentation tools to reduce the time nurses spent on administrative work. The technology reduced documentation time by approximately 15 minutes per shift.
At first, the CFO remained unconvinced. Fifteen minutes did not appear sufficient to justify the organization’s $1.2 million investment.
However, the organization then examined what happened to the workforce after those 15 minutes were returned to employees.
Nurses spent more time with patients, experienced lower levels of burnout, and required less overtime. Most importantly, turnover among nurses declined from 22% to 16%.
That six-point reduction prevented approximately 72 departures annually:1,200 nurses × 6% = 72 avoided departures
The organization estimated that replacing a nurse cost approximately $75,000 in recruiting, temporary staffing, onboarding, and lost productivity. 72 avoided departures × $75,000 = $5.4 million in avoided cost
In addition, overtime expense fell by $850,000 per year. Total annual benefit exceeded $6 million from a $1.2 million investment—a return of more than 400%.
The technology mattered. But the value came from how it changed the employee experience and improved workforce effectiveness.
Companies that fail to invest in training, workflow redesign, and employee adoption are unlikely to see these kinds of returns.
Problem #3: Finance Lacks a Consistent Framework for Measuring Value
The final challenge is that finance often lacks a reliable way to measure the human capital impact of GenAI.
Traditional capital budgeting is designed for tangible assets. Equipment, buildings, and software can be depreciated and tied directly to output. Human capital investments are different. Their value appears through changes in productivity, engagement, retention, quality, and innovation.
Those outcomes are harder to measure and because they are harder to measure, they are often ignored.
This is where a more structured framework becomes essential.
The ISO 30414 Human Capital Reporting standard provides a practical roadmap for quantifying the workforce factors that drive GenAI success. Rather than focusing narrowly on headcount reduction or labor cost, it encourages organizations to measure:
- Human capital ROI
- Revenue per employee
- Workforce productivity
- Learning effectiveness
- Retention
- Internal mobility
- Leadership capability
- Workforce cost efficiency
These measures help CFOs connect workforce improvements to financial performance.
In the professional services example, traditional metrics suggested the GenAI initiative had failed because labor cost remained unchanged. Using a broader framework, the company discovered that consultant productivity, proposal win rates, and revenue generation had all increased.
Likewise, the healthcare system discovered that the initiative increased human capital ROI from 1.7 to 2.2, improved revenue per employee by 4%, reduced turnover, and lowered overtime expense. Those metrics changed the conversation. Instead of debating whether the AI tool itself was “worth it,” finance could see whether the investment improved the effectiveness and efficiency of the workforce.
That is ultimately the question CFOs should be asking.
The companies most likely to succeed with GenAI are not necessarily those with the best technology. They are the ones with the discipline to measure the broader drivers of value and the willingness to invest in the people and processes required to realize it.
For CFOs, the path forward is clear:
- Stop evaluating GenAI only as a technology expense.
- Treat workforce capability as a core driver of return.
- Measure value through human capital outcomes as well as financial results.
- Use a structured framework, such as ISO 30414, to improve visibility and decision-making.
GenAI is not failing because the technology lacks promise. Many companies are failing because they are using the wrong metrics and overlooking the human side of transformation.
The organizations that will generate the greatest return from GenAI will not be those that simply buy the most sophisticated tools. They will be the ones that redesign work, invest in workforce capability, and measure the impact rigorously.
The CFO Agenda: Require a Human Capital Business Case for Every GenAI Investment
The next step for CFOs: require every GenAI initiative to include a human capital business case. Measure not only technology adoption and cost savings, but also productivity, retention, revenue per employee, workforce cost efficiency, and human capital ROI. Use a structured framework such as ISO 30414 to quantify those outcomes, compare results over time, and hold leaders accountable for achieving them.
Companies that do so will not only improve the success rate of their GenAI investments. They will build a stronger, more productive workforce and create a sustainable competitive advantage.
————
The ideas in this article emerged from discussions among the principal members of Human Capital Impact, a consortium of human capital experts focused on advancing evidence-based human capital measurement and disclosure practices grounded in ISO 30414 principles. More information is available at HC-Impact.
Already a Member? Login HERE.
Identify your path to CFO success by taking our CFO Readiness Assessmentᵀᴹ.
Become a Member today and get 30% off on-demand courses and tools!
For the most up to date and relevant accounting, finance, treasury and leadership headlines all in one place subscribe to The Balanced Digest.
Follow us on Linkedin!
